These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35387678)

  • 21. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol.
    Auriacombe M; Roux P; Briand Madrid L; Kirchherr S; Kervran C; Chauvin C; Gutowski M; Denis C; Carrieri MP; Lalanne L; Jauffret-Roustide M;
    BMJ Open; 2019 Feb; 9(2):e023683. PubMed ID: 30796121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community pharmacists' attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey.
    O'Brien C; Klipp S; Jawa R; Wilson JD
    Harm Reduct J; 2024 Jul; 21(1):137. PubMed ID: 39030563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of a de-escalation training intervention in adult acute and forensic units: the EDITION systematic review and feasibility trial.
    Price O; Papastavrou Brooks C; Johnston I; McPherson P; Goodman H; Grundy A; Cree L; Motala Z; Robinson J; Doyle M; Stokes N; Armitage CJ; Barley E; Brooks H; Callaghan P; Carter LA; Davies LM; Drake RJ; Lovell K; Bee P
    Health Technol Assess; 2024 Jan; 28(3):1-120. PubMed ID: 38343036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial.
    Hochstatter KR; Hull SJ; Sethi AK; Burns ME; Mundt MP; Westergaard RP
    J Med Internet Res; 2020 Sep; 22(9):e19703. PubMed ID: 32990630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr Prison, Iran.
    Asl RT; Eshrati B; Dell CA; Taylor K; Afshar P; Kamali M; Mirzazadeh A
    Harm Reduct J; 2013 Dec; 10():41. PubMed ID: 24369092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment.
    Dengo-Baloi L; Boothe M; Semá Baltazar C; Sathane I; Langa DC; Condula M; Ricardo H; Inguane C; Teodoro E; Gouveia L; Raymond HF; Horth R
    BMC Public Health; 2020 Jun; 20(1):975. PubMed ID: 32571365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs.
    Harris MT; Weinberger E; O'Brien C; Althoff M; Paltrow-Krulwich S; Taylor JL; Judge A; Samet JH; Walley AY; Gunn CM
    Addict Sci Clin Pract; 2024 Jun; 19(1):47. PubMed ID: 38831359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs.
    Lambdin BH; Bluthenthal RN; Zibbell JE; Wenger L; Simpson K; Kral AH
    Int J Drug Policy; 2019 Dec; 74():299-304. PubMed ID: 31733979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare providers' knowledge and attitudes about overdose prevention sites in Colorado.
    Paz E; Mashhouri V; Payton ME; Schwartz BD; Linger RMA
    Harm Reduct J; 2024 Aug; 21(1):155. PubMed ID: 39182085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme.
    Peak A; Rana S; Maharjan SH; Jolley D; Crofts N
    AIDS; 1995 Sep; 9(9):1067-70. PubMed ID: 8527080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-related harm among people who inject drugs in Thailand: summary findings from the Mitsampan Community Research Project.
    Hayashi K; Ti L; Fairbairn N; Kaplan K; Suwannawong P; Wood E; Kerr T
    Harm Reduct J; 2013 Oct; 10():21. PubMed ID: 24099081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. People who use drugs engagement in substance use disorder services and harm reduction: evaluation, challenges and future direction of a community-based intervention.
    Gleason-Comstock J; Calhoun CB; Locke BJ; Boorle NVLD; Cobty K; McKenney T; Uddin KO; Bauer SJ; Xu J
    Subst Abuse Treat Prev Policy; 2024 Apr; 19(1):24. PubMed ID: 38689339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review.
    Bouzanis K; Joshi S; Lokker C; Pavalagantharajah S; Qiu Y; Sidhu H; Mbuagbaw L; Qutob M; Henedi A; Levine MAH; Lennox R; Tarride JE; Kalina D; Alvarez E
    BMJ Open; 2021 Sep; 11(9):e047511. PubMed ID: 34556508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study.
    Twahirwa Rwema JO; Nizeyimana V; Prata NM; Okonkwo NE; Mazzei AA; Muhirwa S; Rukundo A; Lucas L; Niyigena A; Makuza JD; Beyrer C; Baral SD; Kagaba A
    Harm Reduct J; 2021 Dec; 18(1):130. PubMed ID: 34911554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C services at harm reduction centres in the European Union: a 28-country survey.
    Pericàs JM; Bromberg DJ; Ocampo D; Schatz E; Wawer I; Wysocki P; Safreed-Harmon K; Lazarus JV
    Harm Reduct J; 2019 Mar; 16(1):20. PubMed ID: 30898122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding the reach of harm reduction in Thailand: experiences with a drug user-run drop-in centre.
    Kerr T; Hayashi K; Fairbairn N; Kaplan K; Suwannawong P; Zhang R; Wood E
    Int J Drug Policy; 2010 May; 21(3):255-8. PubMed ID: 19766474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan.
    Stringer KL; Mukherjee T; McCrimmon T; Terlikbayeva A; Primbetovac S; Darisheva M; Hunt T; Gilbert L; El-Bassel N
    Int J Drug Policy; 2019 Jun; 68():27-36. PubMed ID: 30981165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US.
    Franz B; Dhanani LY; Hall OT; Brook DL; Simon JE; Miller WC
    Harm Reduct J; 2023 Dec; 20(1):180. PubMed ID: 38129903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.